CVE-2026-118458 - Vulnerability Details - OpenCVE

The shared AIS login routing selects a production-shipped test DAO and plaintext comparison for the H and V application codes, accepting fixed administrator accounts.

Attack Vector Network

Attack Complexity Low

Privileges Required None

Attack Requirements None

User Interaction None

Vulnerable System Confidentiality Impact High

Vulnerable System Integrity Impact High

Vulnerable System Availability Impact High

Subsequent System Confidentiality Impact None

Subsequent System Integrity Impact None

Subsequent System Availability Impact None

No CVSS v3.1

No CVSS v3.0

No CVSS v2

This CVE is not in the KEV list.

Key SSVC decision points have not yet been added.

Vendors	Products
Compugroup Medical	Phronesis Venere

No data.

No data.

References

Link	Providers
https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical
https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html

History

Mon, 09 Nov 2026 17:00:00 +0000

Type	Values Removed	Values Added
First Time appeared		Compugroup Medical Compugroup Medical phronesis Compugroup Medical venere
Vendors & Products		Compugroup Medical Compugroup Medical phronesis Compugroup Medical venere

Mon, 09 Nov 2026 12:00:00 +0000

Type	Values Removed	Values Added
Description		The shared AIS login routing selects a production-shipped test DAO and plaintext comparison for the H and V application codes, accepting fixed administrator accounts.
Title		AIS shared test login provider contains fixed administrative credentials
Weaknesses		CWE-798
References		https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html
Metrics		cvssV4_0 `{'score': 8.1, 'vector': 'CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U'}`

MITRE

Status: PUBLISHED

Assigner: ENISA

Published: 2026-11-09T11:46:22.642Z

Updated: 2026-11-09T11:46:22.642Z

Reserved: 2026-10-28T08:46:23.510Z

Link: CVE-2026-118458

Vulnrichment

No data.

NVD

Status : Received

Published: 2026-11-09T12:16:36.583

Modified: 2026-11-09T12:16:36.583

Link: CVE-2026-118458

Redhat

No data.

{"dataType": "CVE_RECORD", "dataVersion": "5.2", "cveMetadata": {"cveId": "CVE-2026-118458", "assignerOrgId": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "state": "PUBLISHED", "assignerShortName": "ENISA", "dateReserved": "2026-10-28T08:46:23.510Z", "datePublished": "2026-11-09T11:46:22.642Z", "dateUpdated": "2026-11-09T11:46:22.642Z"}, "containers": {"cna": {"providerMetadata": {"orgId": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "shortName": "ENISA", "dateUpdated": "2026-11-09T11:46:22.642Z"}, "title": "AIS shared test login provider contains fixed administrative credentials", "problemTypes": [{"descriptions": [{"lang": "en", "cweId": "CWE-798", "description": "CWE-798", "type": "CWE"}]}], "affected": [{"vendor": "CompuGroup Medical", "product": "Phronesis", "versions": [{"status": "affected", "version": "0", "lessThanOrEqual": "5.1.15.1.1", "versionType": "semver"}], "defaultStatus": "unknown", "packageName": "cgm.it.ais.common"}, {"vendor": "CompuGroup Medical", "product": "Venere", "versions": [{"status": "affected", "version": "0", "lessThanOrEqual": "5.1.15.1.1", "versionType": "semver"}], "defaultStatus": "unknown", "packageName": "cgm.it.ais.common"}], "descriptions": [{"lang": "en", "value": "The shared AIS login routing selects a production-shipped test DAO and plaintext comparison for the H and V application codes, accepting fixed administrator accounts.", "supportingMedia": [{"type": "text/html", "base64": false, "value": "<p>The shared AIS login routing selects a production-shipped test DAO and plaintext comparison for the H and V application codes, accepting fixed administrator accounts.</p>"}]}], "references": [{"url": "https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical"}, {"url": "https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html"}], "metrics": [{"format": "CVSS", "scenarios": [{"lang": "en", "value": "GENERAL"}], "cvssV4_0": {"attackVector": "NETWORK", "attackComplexity": "LOW", "attackRequirements": "NONE", "privilegesRequired": "NONE", "userInteraction": "NONE", "vulnConfidentialityImpact": "HIGH", "subConfidentialityImpact": "NONE", "vulnIntegrityImpact": "HIGH", "subIntegrityImpact": "NONE", "vulnAvailabilityImpact": "HIGH", "subAvailabilityImpact": "NONE", "exploitMaturity": "UNREPORTED", "Safety": "NOT_DEFINED", "Automatable": "NOT_DEFINED", "Recovery": "NOT_DEFINED", "valueDensity": "NOT_DEFINED", "vulnerabilityResponseEffort": "NOT_DEFINED", "providerUrgency": "NOT_DEFINED", "version": "4.0", "baseSeverity": "HIGH", "baseScore": 8.1, "vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U"}}], "credits": [{"lang": "en", "value": "Marco Sala", "type": "finder"}, {"lang": "en", "value": "CSIRT-IT", "type": "coordinator"}, {"lang": "en", "value": "ApoCert srl", "type": "finder"}], "x_generator": {"engine": "Vulnogram 1.0.5"}, "source": {"discovery": "UNKNOWN"}}}}

{"affected": [{"affectedData": [{"defaultStatus": "unknown", "packageName": "cgm.it.ais.common", "product": "Phronesis", "vendor": "CompuGroup Medical", "versions": [{"lessThanOrEqual": "5.1.15.1.1", "status": "affected", "version": "0", "versionType": "semver"}]}, {"defaultStatus": "unknown", "packageName": "cgm.it.ais.common", "product": "Venere", "vendor": "CompuGroup Medical", "versions": [{"lessThanOrEqual": "5.1.15.1.1", "status": "affected", "version": "0", "versionType": "semver"}]}], "source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158"}], "cveTags": [], "descriptions": [{"lang": "en", "value": "The shared AIS login routing selects a production-shipped test DAO and plaintext comparison for the H and V application codes, accepting fixed administrator accounts."}], "id": "CVE-2026-118458", "lastModified": "2026-11-09T12:16:36.583", "metrics": {"cvssMetricV40": [{"cvssData": {"Automatable": "NOT_DEFINED", "Recovery": "NOT_DEFINED", "Safety": "NOT_DEFINED", "attackComplexity": "LOW", "attackRequirements": "NONE", "attackVector": "NETWORK", "availabilityRequirement": "NOT_DEFINED", "baseScore": 8.1, "baseSeverity": "HIGH", "confidentialityRequirement": "NOT_DEFINED", "exploitMaturity": "UNREPORTED", "integrityRequirement": "NOT_DEFINED", "modifiedAttackComplexity": "NOT_DEFINED", "modifiedAttackRequirements": "NOT_DEFINED", "modifiedAttackVector": "NOT_DEFINED", "modifiedPrivilegesRequired": "NOT_DEFINED", "modifiedSubAvailabilityImpact": "NOT_DEFINED", "modifiedSubConfidentialityImpact": "NOT_DEFINED", "modifiedSubIntegrityImpact": "NOT_DEFINED", "modifiedUserInteraction": "NOT_DEFINED", "modifiedVulnAvailabilityImpact": "NOT_DEFINED", "modifiedVulnConfidentialityImpact": "NOT_DEFINED", "modifiedVulnIntegrityImpact": "NOT_DEFINED", "privilegesRequired": "NONE", "providerUrgency": "NOT_DEFINED", "subAvailabilityImpact": "NONE", "subConfidentialityImpact": "NONE", "subIntegrityImpact": "NONE", "userInteraction": "NONE", "valueDensity": "NOT_DEFINED", "vectorString": "CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X", "version": "4.0", "vulnAvailabilityImpact": "HIGH", "vulnConfidentialityImpact": "HIGH", "vulnIntegrityImpact": "HIGH", "vulnerabilityResponseEffort": "NOT_DEFINED"}, "source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "type": "Secondary"}]}, "published": "2026-11-09T12:16:36.583", "references": [{"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "url": "https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical"}, {"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "url": "https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html"}], "sourceIdentifier": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "vulnStatus": "Received", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-798"}], "source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "type": "Secondary"}]}